## Abstract CYP1A1 and CYP1A2 enzymes metabolize polycyclic aromatic hydrocarbons (PAHs) to the reactive oxyderivatives. PAHs can induce the activity of both enzymes, which increases its conversion and enhances risk of carcinogenesis. Thus, the inhibition of CYP enzymes is recognized as a cancer ch
β¦ LIBER β¦
In vivo inhibition of human CYP1A2 activity by oltipraz
β Scribed by Gbemiga G. Sofowora; Edna F. Choo; Gail Mayo; Yu Shyr; Grant R. Wilkinson
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 114 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Sulforaphane and its analogues inhibit C
β
Katarzyna Skupinska; Irena Misiewicz-Krzeminska; Rafal Stypulkowski; Katarzyna L
π
Article
π
2009
π
John Wiley and Sons
π
English
β 380 KB
Kinetic characterization of CYP2E1 inhib
β
Patrick D. Lilly; Janice R. Thornton-Manning; Michael L. Gargas; Harvey J. Clewe
π
Article
π
1998
π
Springer-Verlag
π
English
β 565 KB
Dose-dependent inhibition of CYP1A2, CYP
β
U. Jeppesen; L. F. Gram; K. Vistisen; S. Loft; H. E. Poulsen; K. BrΓΈsen
π
Article
π
1996
π
Springer
π
English
β 95 KB
In Vitro/in Vivo scaling of alprazolam m
β
Noriko Hirota; Kiyomi Ito; Takafumi Iwatsubo; Carol E. Green; Charles A. Tyson;
π
Article
π
2001
π
John Wiley and Sons
π
English
β 243 KB
π 1 views
We attempted to predict the in vivo metabolic clearance of alprazolam from in vitro metabolic studies using human liver microsomes and human CYP recombinants. Good correlations were observed between the intrinsic clearance (CL int ) for 4-hydroxylation and CYP3A4 content and between the CL int for a
Detailed characterization of experimenta
β
Sherwin K. B. Sy; Bing-Kou Tang; Aleksandra Pastrakuljic; Eve A. Roberts; Werner
π
Article
π
2001
π
Springer
π
English
β 150 KB
In vivo inhibition profile of cytochrome
β
Transon, Catherine; Leemann, Thierry; Vogt, Nicole; Dayer, Pierre
π
Article
π
1995
π
Nature Publishing Group
π
English
β 802 KB